PRECISION OPTICS CORP INC (POCI) Fundamental Analysis & Valuation
NASDAQ:POCI • US7402944000
Current stock price
4.26 USD
+0.08 (+1.91%)
Last:
This POCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. POCI Profitability Analysis
1.1 Basic Checks
- POCI had negative earnings in the past year.
- POCI had a negative operating cash flow in the past year.
- In the past 5 years POCI always reported negative net income.
- POCI had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- POCI's Return On Assets of -30.21% is in line compared to the rest of the industry. POCI outperforms 43.32% of its industry peers.
- Looking at the Return On Equity, with a value of -74.14%, POCI is in line with its industry, outperforming 41.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.21% | ||
| ROE | -74.14% | ||
| ROIC | N/A |
ROA(3y)-15.79%
ROA(5y)-10.91%
ROE(3y)-25.88%
ROE(5y)-18.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 9.70%, POCI is doing worse than 80.21% of the companies in the same industry.
- POCI's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for POCI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.7% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.22%
GM growth 5Y-12.04%
2. POCI Health Analysis
2.1 Basic Checks
- POCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, POCI has more shares outstanding
- POCI has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for POCI has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -1.63, we must say that POCI is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of POCI (-1.63) is worse than 62.57% of its industry peers.
- POCI has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
- POCI has a better Debt to Equity ratio (0.11) than 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.63 |
ROIC/WACCN/A
WACC8.86%
2.3 Liquidity
- POCI has a Current Ratio of 1.05. This is a normal value and indicates that POCI is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.05, POCI is doing worse than 90.37% of the companies in the same industry.
- A Quick Ratio of 0.62 indicates that POCI may have some problems paying its short term obligations.
- POCI has a worse Quick ratio (0.62) than 91.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.62 |
3. POCI Growth Analysis
3.1 Past
- The earnings per share for POCI have decreased strongly by -43.75% in the last year.
- The Revenue has grown by 30.69% in the past year. This is a very strong growth!
- POCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.99% yearly.
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
Revenue 1Y (TTM)30.69%
Revenue growth 3Y6.78%
Revenue growth 5Y13.99%
Sales Q2Q%62.69%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. POCI Valuation Analysis
4.1 Price/Earnings Ratio
- POCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. POCI Dividend Analysis
5.1 Amount
- No dividends for POCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
POCI Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:POCI (4/29/2026, 1:25:06 PM)
4.26
+0.08 (+1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength10.56
Industry Growth62.11
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)05-14 2026-05-14
Inst Owners25.18%
Inst Owner Change2.66%
Ins Owners16.47%
Ins Owner Change3.88%
Market Cap44.77M
Revenue(TTM)24.42M
Net Income(TTM)-6.92M
AnalystsN/A
Price TargetN/A
Short Float %0.26%
Short Ratio0.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.8 | ||
| P/tB | 156.77 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS2.32
BVpS0.89
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.21% | ||
| ROE | -74.14% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.7% | ||
| FCFM | N/A |
ROA(3y)-15.79%
ROA(5y)-10.91%
ROE(3y)-25.88%
ROE(5y)-18.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.22%
GM growth 5Y-12.04%
F-Score2
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 225.91% | ||
| Cap/Sales | 2.35% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | -1.63 |
F-Score2
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)90.7%
Cap/Depr(5y)86.21%
Cap/Sales(3y)1%
Cap/Sales(5y)1.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.69%
Revenue growth 3Y6.78%
Revenue growth 5Y13.99%
Sales Q2Q%62.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-80.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.48%
OCF growth 3YN/A
OCF growth 5YN/A
PRECISION OPTICS CORP INC / POCI Fundamental Analysis FAQ
What is the fundamental rating for POCI stock?
ChartMill assigns a fundamental rating of 2 / 10 to POCI.
Can you provide the valuation status for PRECISION OPTICS CORP INC?
ChartMill assigns a valuation rating of 0 / 10 to PRECISION OPTICS CORP INC (POCI). This can be considered as Overvalued.
What is the profitability of POCI stock?
PRECISION OPTICS CORP INC (POCI) has a profitability rating of 1 / 10.